Page 1443 - Williams Hematology ( PDFDrive )

1418 Part X: Malignant Myeloid Diseases Chapter 88: Acute Myelogenous Leukemia 1419

161. Marcucci G, Maharry K, Wu Y-Z, et al: IDH1 and IDH2 gene mutations identify novel 192. Morton LM, Dores GM, Tucker MA, et al: Evolving risk of therapy-related acute
molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A myeloid leukemia following cancer chemotherapy among adults in the United States,
Cancer and Leukemia Group B study. J Clin Oncol 28:2348, 2010. 1975–2008. Blood 121:2996, 2013.
162. Janin M, Mylonas E, Saada V, et al: Serum-2-hydroxyglutarate production in IDH1- 193. Stanley M, McKenna RW, Ellinger G, Brunning RD: Classification of 358 cases of
and IDH2-mutated de novo acute myeloid leukemia: A study by the Acute Leukemia acute myeloid leukemia by FAB criteria: Analysis of clinical and morphologic features,
French Association Group. J Clin Oncol 32:297, 2013. in Chronic and Acute Leukemias in Adults, edited by Bloomfield CD, p 147. Martinus
163. Dinardo CD, Propert KJ, Loren AW, et al: Serum 2-hydroxyglutarate levels predict Nijhoff, Boston, 1985.
isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. 194. Paietta E: Classification of acute leukemias: Proposals for the immunological classifi-
Blood 121;4917, 2013. cation of acute leukemias. Leukemia 9:2147, 1995.
164. Chaturvedi A, Cruz MMA, Jyotsana N, et al: Mutant IDH1 promotes leukemogenesis 195. Kheiri SA, MacKerrell T, Bonagura VR, et al: Flow cytometry with or without cyto-
in vivo and can be specifically targeted in human AML. Blood 122:2877, 2013. chemistry for the diagnosis of acute leukemias? Cytometry 34:82, 1998.
165. Krauth MT, Alpermann T, Bacher U, et al: WT1 mutations are secondary events in 196. Arber B, Brunning R, LeBeau M, et al: Acute myeloid leukemia with recurrent genetic
AML, show varying frequencies and impact on prognosis between genetic subgroups. abnormalities, in WHO Classification of Tumors of Hematopoietic and Lymphoid Tis-
Leukemia 29:660, 2015. sues, ed 4, edited by Swerdlow S, Compo E, Harris NL, p 110. World Health Organiza-
166. Damm F, Heuser M, Morgan M, et al: Single nucleotide polymorphism in the muta- tion, Geneva, 2008.
tional hotspot of WT1 predicts a favorable outcome in patients with cytogenetically 197. Boggs DR, Wintrobe MM, Cartwright GE: The acute leukemias. Analysis of 322 cases
normal acute myeloid leukemia. J Clin Oncol 28:473, 2009. and review of the literature. Medicine (Baltimore) 41:163, 1962.
167. Becker H, Marcucci G, Maharry K, et al: Mutations of the Wilms tumor 1 gene (WT1) 198. Roath S, Isräels MCG, Wilkinson JF: The acute leukemias: A study of 580 patients. Q
in older patients with primary cytogenetically normal acute myeloid leukemia: A J Med 33:256, 1964.
Cancer and Leukemia Group B study. Blood 116;788, 2010. 199. Choi SI, Simone JV: Acute nonlymphocytic leukemia in 171 children. Med Pediatr Oncol
168. Yi JH, Huh J, Kin H-J, et al: Adverse prognostic impact of abnormal lesions detected 2:119, 1976.
by genome-wide single nucleotide polymorphism array-based karyotyping analysis in 200. Chessels JM, O’Calloghan U, Hardisty RM: Acute myeloid leukaemia in childhood:
acute myeloid leukemia with normal karyotype. J Clin Oncol 29:4702, 2011. Clinical features and prognosis. Br J Haematol 63:555, 1986.
169. Kornblau SM, McCue D, Singh N, et al:, Recurrent expression signatures of cytokines 201. Burns CP, Armitage JO, Frey AL, et al: Analysis of presenting features of adult leuke-
and chemokines are present and are independently prognostic in acute myelogenous mia. Cancer 47:2460, 1981.
leukemia and myelodysplasia. Blood 116:4251, 2010. 202. Goodall PT, Vosti KL: Fever in acute myelogenous leukemia. Arch Intern Med 135:
170. Rapin N, Bagger FO, Jendholm J, et al: Comparing cancer vs normal gene expression 1197, 1975.
profiles identifies new disease entities and common transcriptional programs in AML 203. Burke PJ, Braine HG, Rothbun HK, Owens AH: The clinical significance and manage-
patients. Blood 123:894, 2014. ment of fever in acute myelocytic leukemia. Johns Hopkins Med J 139:1, 1976.
171. Eisfled A-K, Marcucci G, Maharry K, et al: mIR-3151 interplays with its host gene 204. Chang JC: How to differentiate neoplastic fever from infectious fever in patients with
BAALC and independently affects outcome of patients with cytogenetically normal cancer. Usefulness of the naproxen test. Heart Lung 16:122, 1987.
acute myeloid leukemia. Blood 120:249, 2012. 205. Gollard RP, Robbins BA, Piro L, Saven A: Acute myelogenous leukemia presenting
172. Shen Y, Zhyu Y-M, Fan X, et al: Gene mutation patterns and their prognostic impact with bulky lymphadenopathy. Acta Haematol 95:129, 1996.
in a cohort of 1185 patients with acute myeloid leukemia. Blood 118:5593, 2011. 206. Davey DD, Fourcar K, Burns CP, Goekin JA: Acute myelocytic leukemia manifested
173. Diffner E, Beck D, Gudgin E, et al: Activity of a heptad of transcription factors is asso- by prominent generalized lymphadenopathy. Am J Hematol 21:89, 1986.
ciated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood 207. Tobelem G, Jacquillat C, Chastang C, et al: Acute monoblastic leukemia: A clinical
121:2289, 2013. and biologic study of 74 cases. Blood 55:71, 1980.
174. Gutierrez SE, Romero-Oliva FA. Epigenetic changes: A common theme in acute 208. Sepp N, Radaszkiewicz T, Meijer CJ, et al: Specific skin manifestations in acute leuke-
myelogenous leukemogenesis. J Hematol Oncol 6:57, 2013. mia with monocytic differentiation. Cancer 71:124, 1993.
175. Schoofs T, Berdel WE, Muller-Tidow C: Origins of aberrant DNA methylation in acute 209. Hejmadi RK, Thompson D, Shah F, Naresh KN: Cutaneous presentation of aleuke-
myeloid leukemia. Leukemia 28:1, 2014. mic monoblastic leukemia cutis—A case report and review of literature with focus on
176. Scholl C, Gilliland DG, Fröhling S: Deregulation of signaling pathways in acute mye- immunohistochemistry. J Cutan Pathol 35:46, 2008.
loid leukemia. Semin Oncol 35:336, 2008. 210. Cibull TL, Thomas AB, O’Malley DP, Billings SD: Myeloid leukemia cutis: A histologic
177. Greaves MF, Maia AT, Wiemels JL, Ford AM: Leukemia in twins: Lessons in natural and immunohistochemical review. J Cutan Pathol 35:180, 2008.
history. Blood 102:2321, 2003. 211. Kaiserling E, Horny H-P, Geerts M-L, Schmid U: Skin involvement in myelogenous
178. Wiemels JL, Xiao Z, Buffler PA, et al: In utero origin of t(8;21) AML1-ETO transloca- leukemia. Morphologic and immunophenotypic heterogeneity of skin infiltrates. Mod
tion in childhood acute leukemia. Blood 99:3801, 2002. Pathol 7:771, 1994.
179. Groves FD, Linet MS, Devesa SS: Epidemiology of leukemia, in Leukemia, ed 6, edited 212. Longacre TA, Smoller BR: Leukemia cutis: Analysis of 50 biopsy-proven cases with
by Henderson ES, Lister TA, Greaves MF, p 145. WB Saunders, New York, 1986. an emphasis on occurrences in myelodysplastic syndromes. Am J Clin Pathol 100:276,
180. Goldin LR, Kristinsson SY, Liang XS, et al: Familial aggregation of acute myeloid leu- 1993.
kemia and myelodysplastic syndromes. J Clin Oncol 30:179, 2011. 213. Cho-Vega JH, Medeiros LJ, Prieto VG, Vega F: Leukemia cutis. Am J Clin Pathol
181. Hahn CN, Chong C-E, Carmichael CL, et al: Heritable GATA2 mutations associ- 129:130, 2008.
ated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 214. Bourantas K, Malamou-Mitsi V, Christou L, et al: Cutaneous vasculitis as the initial
43:1012, 2012. manifestation in acute myelomonocytic leukemia. Ann Intern Med 121:942, 1994.
182. Ostergaard P, Simpson MA, Connell FC, et al: Mutations in GATA2 cause primary 215. Sheps M, Shapero H, Ramsay C: Bullous pyoderma gangrenosum and acute leukemia.
lymphedema associated with a predisposition to acute myeloid leukemia (Emberger Arch Dermatol 114:1842, 1978.
syndrome). Nat Genet 43:929, 2011. 216. Lewis SJ, Poh-Fitzpatrick MB, Walther RR: A typical pyoderma gangrenosum with
183. Calvo KR, Vihn DC, Maric I, et al: Myelodysplasia in autosomal dominant and spo- leukemia. JAMA 239:935, 1978.
radic monocytopenia immunodeficiency syndrome: Diagnostic features and clinical 217. Cohen PR: Sweet’s syndrome—A comprehensive review of an acute febrile
implications. Haematologica 96:1221, 2010. neutrophilic dermatosis. Orphanet J Rare Dis 26(2):34, 2007.
184. Kazenwadel J, Secker GA, Liu YJ, et al: Loss-of-function germline GATA2 mutations 218. Cheson BD, Christensen RM: Cutis verticis gyrata: Unusual chloromatous disease in
in patients with MDS/AML or MonoMAC syndrome and primary lymphedema acute myelogenous leukemia. Am J Hematol 8:415, 1980.
reveal a key role for GATA2 in the lymphatic vasculature. Blood 119:1283, 2012. 219. Stern M, Halter J, Buser A, et al: Leukemia cutis preceding systemic relapse of acute
185. Smith ML, Cavenagh JD, Lister A, Fitzgibbon J: Mutation of CEBPA in familial acute myeloid leukemia. Int J Hematol 87:108, 2008.
myeloid leukemia. N Engl J Med 351:2403, 2004. 220. Markowski TR, Martin DB, Kao GF, et al: Leukemia cutis: A presenting sign in acute
186. Holme H, Hossain U, Kirwan M, et al: Marked genetic heterogeneity in familial promyelocytic leukemia. Arch Dermatol 143:1220, 2007.
myelodysplasia/acute myeloid leukaemia. Br J Haematol 158:242, 2012. 221. Long JC, Mihm MC: Multiple granulocytic tumors of the skin: Report of six cases of
187. Kirwan M, Vuillamy T, Marrone A, et al: Defining the pathogenic role of telomerase muta- myelogenous leukemia with initial manifestations in the skin. Cancer 39:2004, 1977.
tions in myelodysplastic syndrome and acute myeloid leukemia. Hum Mutat 30:1567, 222. Rallis E, Stavropoulou E, Michalakeas I, et al: Monoblastic sarcoma cutis preceding
2009. acute monoblastic leukemia. Am J Hematol 84:590, 2008.
188. Vickers M, Jackson G, Taylor P: The incidence of acute promyelocytic leukemia appears 223. Kincaid MC, Green WR: Ocular and orbital involvement in leukemia. Surv Ophthal-
constant over most of a human life span, implying only one rate limiting mutation. mol 27:211, 1983.
Leukemia 14:727, 2000. 224. Paparella MM, Berlinger NT, Oda M: Otological manifestations of leukemia. Laryngo-
189. Chongli Y, Xiaobo Z: Incidence survey of leukemia in China. Chinese J Med Sci 6:65, scope 83:1510, 1973.
1991. 225. Bertrand Y, Lefrère JJ, Leverger G, et al: Acute myeloblastic leukemia presenting as
190. Douer D, Santillana S, Ramezani L, et al: Acute promyelocytic leukaemia in patients apparent acute otitis media. Am J Hematol 27:136, 1988.
originating in Latin America is associated with an increased frequency of the bcr1 226. Shiknecht HF, Igarashi M, Chasin WD: Inner ear hemorrhage in leukemia. Laryngo-
subtype of the PML/RARalpha fusion gene. Br J Haematol 122:563, 2003. scope 75:662, 1965.
191. Otero JC, Santillana S, Fereyros G: High frequency of acute promyelocytic leukemia 227. Dewar GJ, Lim CN, Michalyshyn B, Akabutu J: Gastrointestinal complications in
among Latinos with acute myeloid leukemias. Blood 88:377, 1996. patients with acute and chronic leukemia. Can J Surg 24:67, 1981.

Kaushansky_chapter 88_p1373-1436.indd 1418 9/21/15 11:02 AM